Company: Eden, Denver CO
Nomination Submitted by: HLTH Communications
Company Description: Eden is a digital health company focused on connecting patients with doctors and licensed compounding pharmacies to deliver personalized metabolic health programs. Trusted by over 50,000 members, Eden's goal is to make healthcare accessible and supportive for individuals seeking to improve how they look, feel, and perform. For more information, visit tryeden.com
Nomination Category: Company / Organization Categories
Nomination Sub Category: Startup of the Year - Consumer Services Industries
 Nomination Title: Eden
- Which will you submit for your nomination in this category, a video of up to five (5) minutes in length about the achievements of the nominated organization since January 1 2023, OR written answers to the questions for this category? (Choose one):
Written answers to the questions
- If you are submitting a video of up to five (5) minutes in length, provide the URL of the nominated video here, OR attach it to your entry via the "Add Attachments, Videos, or Links to This Entry" link above, through which you may also upload a copy of your video.
Written
- If you are providing written answers for your submission, you must provide an answer to this first question: Briefly describe the nominated organization: its history and past performance (up to 200 words):
Total 165 words used.
Eden (TryEden.com) is a cutting-edge telehealth company revolutionizing medical weight management by providing affordable, accessible, and personalized treatment options. Founded to address the growing demand for GLP-1 weight loss medications, Eden eliminates traditional healthcare barriers by offering direct-to-consumer prescriptions with transparent pricing and comprehensive patient support.
Eden's approach goes beyond prescriptions—unlike many competitors, it provides ongoing medical oversight, personalized treatment adjustments, and lifestyle guidance to ensure sustainable weight loss. The company also distinguishes itself through innovation, offering compounded GLP-1 medications and a gummy supplement line, making weight management more convenient for patients.
In a short time, Eden has positioned itself as a leader in the telehealth weight loss space, earning trust through affordability, medical excellence, and customer-centric care. By removing insurance complications and streamlining access to clinically proven treatments, Eden is not just keeping up with the industry—it’s redefining it. Its rapid growth and positive patient outcomes demonstrate its success, solidifying its reputation as a standout healthcare provider in the evolving digital health landscape.
- If you are providing written answers for your submission, you must provide an answer to this second question: Outline the organization's achievements since the beginning of 2023 that you wish to bring to the judges' attention (up to 250 words):
Total 199 words used.
Since early 2023, Eden has emerged as a leader in medical weight management, achieving remarkable milestones in accessibility, innovation, and patient care.
Key Achievements:
-
Expansion of Compounded GLP-1 Medications: Addressing medication shortages and affordability concerns, Eden introduced compounded versions of GLP-1 treatments, making weight loss solutions more accessible.
-
Launch of Gummy Supplement: Eden launched a gummy supplement line, providing an alternative weight management solution that complements its prescription offerings. This innovation has set Eden apart from competitors by offering a more flexible, patient-friendly approach.
-
Unmatched Affordability & Transparency: While many competitors impose hidden fees and high markups, Eden has maintained clear, upfront pricing, ensuring patients receive high-quality treatment without financial barriers.
-
Rapid Patient Growth & Retention: Eden has experienced substantial user growth, with high retention rates attributed to personalized care, medical oversight, and treatment customization.
-
Industry Recognition & Market Expansion: By leveraging cutting-edge telehealth technology, Eden has expanded its reach nationwide, becoming a trusted name in medical weight loss.
Eden’s patient-first philosophy, innovative product development, and commitment to affordability have positioned it as a game-changer in the telehealth weight loss industry. Its unwavering dedication to accessibility and medical excellence makes it a strong contender for Company of the Year.
- If you are providing written answers for your submission, you must provide an answer to this third question: Explain why the achievements you have highlighted are unique or significant. If possible compare the achievements to the performance of other players in your industry and/or to the organization's past performance (up to 250 words):
Total 200 words used.
Eden’s achievements stand out in a competitive telehealth market where affordability, accessibility, and innovation define success. Compared to major industry players like Hims & Hers, HenryMeds, and WeightWatchers, Eden has differentiated itself through transparency, patient-focused care, and product innovation.
Key Differentiators:
-
Compounded GLP-1 Medications: While companies like Hims & Hers and WeightWatchers offer GLP-1 prescriptions, they rely on retail pharmacy pricing and supply chains, often leading to high costs and shortages. Eden tackled this issue by providing compounded semaglutide and tirzepatide, making these treatments more affordable and widely available without the insurance roadblocks
-
Gummy Supplement Line: Unlike competitors that focus solely on injections, Eden introduced a first-of-its-kind gummy supplement line, offering patients an alternative, easier-to-use weight management option.
-
Affordability & Transparency: Unlike WeightWatchers, which bundles medication access with membership fees, or HenryMeds, which lacks robust patient support, Eden maintains clear, upfront pricing with no hidden costs
-
Unparalleled Patient Support & Retention: Many competitors focus on prescription fulfillment without follow-up care. Eden, however, provides ongoing medical oversight and treatment customization, leading to higher patient retention and improved long-term results.
By directly addressing industry shortcomings while continuously improving access, innovation, and patient experience, Eden has outpaced competitors and exceeded its own performance.
- You have the option to answer this final question: Reference any attachments of supporting materials throughout this nomination and how they provide evidence of the claims you have made in this nomination (up to 250 words):
Total 5 words used.
https://www.prnewswire.com/news-releases/eden-unveils-the-worlds-first-compounded-glp-1-rx-gummy-302340675.html
| Attachments/Videos/Links: |
|---|
| Eden |
|---|
 |
[REDACTED FOR PUBLICATION] |
|
